33 min listen
CDKN2A homozygous deletion in IDH mutant astrocytoma
CDKN2A homozygous deletion in IDH mutant astrocytoma
ratings:
Length:
39 minutes
Released:
Oct 8, 2022
Format:
Podcast episode
Description
Dr. Evan Noch interviews Drs. Shannon Fortin Ensign and Sani Kizilbash about their recent paper in Neuro-Oncology entitled: "Translational significance of CDKN2A/B homozygous deletion in IDH mutant astrocytoma", published online in Neuro-Oncology in August 2022 Full Report
Released:
Oct 8, 2022
Format:
Podcast episode
Titles in the series (84)
Vorinostat and bevacizumab for recurrent glioblastoma: Dr. Iyad Alnahhas interviews Drs. Vinay Puduvalli and Ying Yuan about their paper "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma" published in Neuro-Oncology... by Neuro-Oncology: The Podcast